
Sotera Health (SHC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
254.5M
Gross Profit
135.4M
53.21%
Operating Income
57.0M
22.41%
Net Income
-13.3M
-5.21%
EPS (Diluted)
$-0.05
Balance Sheet Metrics
Total Assets
3.1B
Total Liabilities
2.7B
Shareholders Equity
414.1M
Debt to Equity
6.48
Cash Flow Metrics
Operating Cash Flow
58.7M
Free Cash Flow
35.6M
Revenue & Profitability Trend
Sotera Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.1B | 1.0B | 1.0B | 931.5M | 818.2M |
Cost of Goods Sold | 498.1M | 472.1M | 446.7M | 412.8M | 374.6M |
Gross Profit | 602.3M | 577.2M | 557.0M | 518.7M | 443.6M |
Gross Margin % | 54.7% | 55.0% | 55.5% | 55.7% | 54.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 242.6M | 236.7M | 245.7M | 198.2M | 178.5M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 242.6M | 236.7M | 245.7M | 198.2M | 178.5M |
Operating Income | 297.6M | 276.7M | 248.4M | 256.7M | 206.0M |
Operating Margin % | 27.0% | 26.4% | 24.7% | 27.6% | 25.2% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 164.7M | 142.9M | 80.1M | 74.2M | 215.3M |
Other Non-Operating Income | -19.1M | -27.8M | -411.3M | -6.8M | -29.6M |
Pre-tax Income | 113.9M | 106.0M | -243.1M | 175.7M | -38.9M |
Income Tax | 69.5M | 54.7M | -9.5M | 58.6M | -1.4M |
Effective Tax Rate % | 61.0% | 51.5% | 0.0% | 33.3% | 0.0% |
Net Income | 44.4M | 51.4M | -233.6M | 117.1M | -37.5M |
Net Margin % | 4.0% | 4.9% | -23.3% | 12.6% | -4.6% |
Key Metrics | |||||
EBITDA | 466.6M | 442.0M | 400.3M | 422.8M | 359.0M |
EPS (Basic) | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.16 |
EPS (Diluted) | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.16 |
Basic Shares Outstanding | 282784000 | 281008000 | 280096000 | 279228000 | 237696000 |
Diluted Shares Outstanding | 282784000 | 281008000 | 280096000 | 279228000 | 237696000 |
Income Statement Trend
Sotera Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 277.2M | 296.4M | 395.2M | 106.9M | 102.4M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 140.3M | 147.7M | 118.5M | 108.2M | 91.7M |
Inventory | 49.2M | 48.3M | 37.1M | 54.3M | 34.1M |
Other Current Assets | 12.3M | 14.4M | 12.8M | 10.7M | 10.7M |
Total Current Assets | 526.0M | 557.2M | 645.0M | 346.0M | 315.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 34.9M | 30.6M | 30.7M | 44.1M | 49.9M |
Goodwill | 2.5B | 2.6B | 2.7B | 2.8B | 2.9B |
Intangible Assets | 317.7M | 416.3M | 491.3M | 598.8M | 643.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 39.9M | 46.2M | 43.1M | 18.8M | 17.7M |
Total Non-Current Assets | 2.5B | 2.6B | 2.5B | 2.4B | 2.4B |
Total Assets | 3.1B | 3.1B | 3.1B | 2.8B | 2.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 55.1M | 71.0M | 74.1M | 72.9M | 52.4M |
Short-term Debt | 22.8M | 19.5M | 206.4M | 10.4M | 10.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 4.1M | 414.0K | 3.5M | - | 670.0K |
Total Current Liabilities | 191.0M | 230.7M | 791.6M | 161.2M | 140.6M |
Non-Current Liabilities | |||||
Long-term Debt | 2.3B | 2.3B | 1.8B | 1.8B | 1.9B |
Deferred Tax Liabilities | 69.5M | 64.5M | 68.0M | 134.5M | 121.8M |
Other Non-Current Liabilities | 4.4M | 8.9M | 12.8M | 16.3M | 17.5M |
Total Non-Current Liabilities | 2.5B | 2.5B | 2.0B | 2.0B | 2.2B |
Total Liabilities | 2.7B | 2.7B | 2.8B | 2.2B | 2.3B |
Equity | |||||
Common Stock | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M |
Retained Earnings | -610.0M | -654.4M | -705.8M | -472.2M | -589.1M |
Treasury Stock | 23.4M | 27.2M | 29.8M | 33.5M | 34.0M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 404.9M | 443.7M | 350.2M | 586.1M | 454.6M |
Key Metrics | |||||
Total Debt | 2.4B | 2.3B | 2.0B | 1.8B | 1.9B |
Working Capital | 335.0M | 326.6M | -146.6M | 184.8M | 174.4M |
Balance Sheet Composition
Sotera Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 44.4M | 51.4M | -233.6M | 117.1M | -37.5M |
Depreciation & Amortization | 163.6M | 157.9M | 145.6M | 150.9M | 143.6M |
Stock-Based Compensation | 36.8M | 32.2M | 21.2M | 13.9M | 11.0M |
Working Capital Changes | -49.7M | -406.8M | 388.6M | -14.2M | -15.0M |
Operating Cash Flow | 233.2M | -155.7M | 248.8M | 259.7M | 86.7M |
Investing Activities | |||||
Capital Expenditures | -179.1M | -215.0M | -182.4M | -102.2M | -53.5M |
Acquisitions | 0 | 0 | 450.0K | -57.0M | -105.2M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -179.0M | -214.9M | -181.9M | -159.8M | -158.7M |
Financing Activities | |||||
Share Repurchases | -4.4M | -4.1M | -393.0K | -1.4M | -34.0M |
Dividends Paid | - | - | - | 0 | 0 |
Debt Issuance | 2.3B | 500.0M | 200.0M | 0 | 150.0M |
Debt Repayment | -2.3B | -202.5M | 0 | -100.0M | -1.2B |
Financing Cash Flow | -2.3B | 63.5M | 197.8M | -217.3M | -953.9M |
Free Cash Flow | 45.1M | -362.7M | 95.6M | 179.4M | 67.1M |
Net Change in Cash | -2.3B | -307.1M | 264.6M | -117.4M | -1.0B |
Cash Flow Trend
Sotera Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
181.89
Forward P/E
20.21
Price to Book
9.09
Price to Sales
4.13
PEG Ratio
20.21
Profitability Ratios
Profit Margin
2.14%
Operating Margin
35.34%
Return on Equity
5.14%
Return on Assets
7.24%
Financial Health
Current Ratio
2.47
Debt to Equity
460.02
Beta
1.81
Per Share Data
EPS (TTM)
$0.09
Book Value per Share
$1.80
Revenue per Share
$3.97
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
shc | 3.3B | 181.89 | 9.09 | 5.14% | 2.14% | 460.02 |
Thermo Fisher | 197.5B | 28.50 | 3.68 | 13.42% | 15.24% | 69.62 |
Danaher | 147.0B | 43.70 | 2.82 | 6.68% | 14.21% | 35.45 |
Exact Sciences | 9.0B | -8.48 | 3.63 | -35.51% | -34.19% | 102.73 |
Guardant Health | 5.0B | -18.68 | -27.02 | 312.48% | -49.93% | -4.37 |
Qiagen N.V | 8.3B | 27.51 | 2.88 | 10.81% | 18.30% | 42.31 |
Financial data is updated regularly. All figures are in the company's reporting currency.